Main > ONCOLOGY (**) > Esophageal>Squamous>Advanced>MET> > TREAT.: > USA. B. PD-1 Binding MAb+CT

---

USA. B. PD-1 Binding MAb+CT's subsections
(*) EU CE Mark Date: 2022. 04.05.
Company
Generic Name: NivoluMAb
Patent>Assignee; Claims; No.; Etc.
RTM
RTM Web-Site

USA. B. PD-1 Binding MAb+CT's products
This section has no products